Immunovant Inc IMVT 深 沪
已收盘 05-22 16:00:00 美东时间
34.15
+0.020
+0.06%
华盛通- 最 高34.95
- 今 开34.17
- 成交量 168.55万股
- 最 低 33.59
- 昨 收 34.13
- 总市值 70.11亿
- 52周最高 36.285
- 市盈率 静 --
- 换手率 0.82%
- 52周最低 14.32
- 委 比 -8.15%
- 总股本 2.05亿
- 历史最高 53.75
- 量 比 0.30
- 振 幅 3.98%
- 历史最低 3.145
- 每 手 1
- 风险率 5.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 英伟达绩后获11家大行集体上调目标价；劳氏、ELF、Intuit、VF等惨遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx药业"超配"评级，目标价从84美元升至96美元；Ascendiant Capital：维持Liqtech国际"买入"评级，目标价从4.3美元升至4.4美元
05-22 10:18
HC Wainwright & Co. Maintains Buy on Immunovant, Raises Price Target to $40
HC Wainwright & Co. analyst Douglas Tsao maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from $35 to $40.
05-21 19:12
美股牛股 | TE飙升26%，获罗斯资本反驳做空机构对其质疑；TAT科技大涨21%
TE飙升26%，获罗斯资本反驳做空机构对其质疑；TAT科技大涨21%，Q1每股盈利、销售额均超预期；SLS大涨18%，关键期试验临床数据即将公布>>
05-21 19:32
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA May 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Analog Devices, Intuit and NVIDIA, on Thursday. HIGHLIGHTS * Analog Devices Inc ADI.O : Jefferies raises target
05-21 14:42
Immunovant director Atul Pande disposes 6,000 shares for $192,000
Immunovant director Atul Pande disposes 6,000 shares for $192,000 Immunovant director Atul Pande reported selling 6,000 common shares at USD 32 on May 20, 2026. The sale followed the exercise of 6,000 stock options at USD 8.43 per share on the same day. Pande’s direct common share holdings fell to 1
05-21 09:22
Immunovant Stock Surges Despite Disappointing Earnings Miss
Immunovant Inc (NASDAQ: IMVT) shares are trading higher Wednesday despite posting a wider-than-expected fourth‑quarter loss.
05-21 01:09
Roivant gains after mid-stage trial data for Immunovant’s main asset
Roivant Sciences (ROIV) traded sharply higher after its subsidiary Immunovant (IMVT) posted initial results from a Phase 2 trial evaluating its lead asset IMVT-1402 in rheumatoid arthritis, an autoimm...
05-20 22:10
Roivant Sciences Reports Q4 2026 Results: Full Earnings Call Transcript
Roivant Sciences (NASDAQ:ROIV) reported fourth-quarter financial results on Wed...
05-20 21:28
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 147.2% to ...
05-20 20:06
财报速睇 | Immunovant Inc 2026财年年度营收0.00亿美元，同比增长0.0%；归母净利润亏损5.06亿美元，同比亏损扩大22.2%
华盛资讯5月20日讯，Immunovant Inc公布2026财年年度业绩，公司年度营收0.00亿美元，同比增长0.0%，归母净利润亏损5.06亿美元，同比亏损扩大22.2%。
05-20 19:47
